<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of the patient with HIV, odynophagia, and dysphagia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of the patient with HIV, odynophagia, and dysphagia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of the patient with HIV, odynophagia, and dysphagia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">C Mel Wilcox, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul E Sax, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 21, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients with human immunodeficiency virus (HIV; PWH) and advanced immunodeficiency are at risk for esophagitis, which can be severe, and require hospitalization if the patient cannot swallow liquids. This topic addresses the evaluation of the PWH and odynophagia and/or dysphagia. The clinical manifestations and treatment of esophageal candidiasis are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2427.html" rel="external">"Esophageal candidiasis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">"Oropharyngeal candidiasis in adults"</a>.)</p><p class="headingAnchor" id="H19604928"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Patients who have not attained immune reconstitution on combination antiretroviral therapy (ART) or who are not taking ART are at risk of developing esophagitis [<a href="#rid1">1</a>]. Those with a CD4 cell count &lt;100 cells/microL are at particularly high risk.</p><p class="headingAnchor" id="H19605015"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Esophagitis in patients with acquired immunodeficiency syndrome (AIDS) is most often related to <em>Candida</em> infection; less commonly, it represents herpes simplex virus infection, cytomegalovirus infection, or aphthous (idiopathic) ulcers. (See  <a class="medical medical_review" href="/z/d/html/2416.html" rel="external">"Overview of Candida infections", section on 'Esophagitis'</a> and  <a class="medical medical_review" href="/z/d/html/8306.html" rel="external">"Herpes simplex virus infection of the esophagus"</a> and  <a class="medical medical_review" href="/z/d/html/8289.html" rel="external">"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults", section on 'Gastrointestinal manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/112654.html" rel="external">"Recurrent aphthous stomatitis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ASSESSMENT</span><span class="headingEndMark"> — </span>A history of odynophagia (pain with swallowing, typically in the chest) or dysphagia (defined as difficulty with passage of food from the oropharynx through the esophagus) should prompt concern about possible esophagitis. Although the presence of oropharyngeal candidal infection (thrush) is predictive of esophageal involvement in patients with HIV and odynophagia or dysphagia, its absence does not rule it out. In one series, 18 percent of patients with <em>Candida</em> esophagitis did not have thrush [<a href="#rid2">2</a>].</p><p>In two prospective studies, <em>Candida</em> esophagitis was detected by endoscopy in up to 64 percent of symptomatic patients [<a href="#rid3">3,4</a>]. If odynophagia rather than dysphagia is the most prominent symptom, <em>Candida</em> esophagitis is less probable. The patient with severe odynophagia without dysphagia or thrush is more likely to have ulcerative esophagitis caused by idiopathic or cytomegalovirus infection. Rarely, esophageal lymphoma may be diagnosed [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H3"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Most clinicians treat PWH and odynophagia and/or dysphagia (especially if they also have thrush) with an empiric course of <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">fluconazole</a> (100 to 200 mg/day orally after a 200 mg loading dose) prior to proceeding with endoscopy since <em>Candida</em> infection is so common [<a href="#rid6">6</a>]. Improvement in symptoms should be expected within five to seven days. Treatment duration is generally one to two weeks. (See  <a class="medical medical_review" href="/z/d/html/2432.html" rel="external">"Oropharyngeal candidiasis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2427.html" rel="external">"Esophageal candidiasis in adults"</a>.)</p><p>If there is no response to treatment, endoscopy with biopsy is required to establish a specific etiology (<a class="graphic graphic_picture graphicRef65075" href="/z/d/graphic/65075.html" rel="external">picture 1</a>) [<a href="#rid2">2</a>]. In one series, 77 percent of patients failing empiric therapy were found to have esophageal ulcers on subsequent endoscopy [<a href="#rid7">7</a>]. History of the biopsied tissue is more specific than culture because a positive culture alone can be indicative of colonization rather than infection [<a href="#rid8">8</a>].</p><p>Conventional <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">barium</a> swallow radiography is not recommended [<a href="#rid9">9</a>]. A randomized trial comparing barium esophagography with endoscopy in symptomatic PWH found endoscopy to be much more sensitive (98 versus 25 percent) for the diagnosis of <em>Candida</em> infection [<a href="#rid10">10</a>]. The radiographic appearance of an esophageal ulcer is not sufficiently specific to distinguish among the various etiologies. Although a multiphasic, double-contrast technique may increase sensitivity [<a href="#rid9">9</a>], endoscopy and biopsy are still required to make a definitive diagnosis. Furthermore, many patients with odynophagia are unable to swallow barium, resulting in an inadequate study.</p><p class="headingAnchor" id="H19605023"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Immunocompromised patients who are not taking antiretroviral therapy (ART) or who have not attained immune reconstitution on ART are at risk of developing esophagitis. Those with a CD4 cell count &lt;100 cells/microL are at particularly high risk. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Esophagitis in this setting is most often related to <em>Candida</em> infection; less commonly, it represents herpes simplex virus infection, cytomegalovirus infection, or aphthous (idiopathic) ulcers. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A history of odynophagia (pain with swallowing, typically in the chest) or dysphagia (defined as difficulty with passage of food from the oropharynx through the esophagus) should prompt concern about possible esophagitis. (See <a class="local">'Assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most clinicians treat patients with HIV and odynophagia and/or dysphagia (especially if they also have thrush) with an empiric course of <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">fluconazole</a> (100 to 200 mg/day orally after a 200 mg loading dose) prior to proceeding with endoscopy since <em>Candida</em> infection is so common. Improvement in symptoms should be expected within five to seven days. Treatment duration is generally one to two weeks. If there is no response to treatment, endoscopy with biopsy is required to establish a specific etiology. (See <a class="local">'Management'</a> above.)</p><p></p><p class="headingAnchor" id="H40483296"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed as Section Editor on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mönkemüller KE, Lazenby AJ, Lee DH, et al. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 2005; 50:230.</a></li><li><a class="nounderline abstract_t">Wilcox CM, Straub RF, Clark WS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration. Am J Gastroenterol 1995; 90:1938.</a></li><li><a class="nounderline abstract_t">Connolly GM, Hawkins D, Harcourt-Webster JN, et al. Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut 1989; 30:1033.</a></li><li><a class="nounderline abstract_t">Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med 1991; 151:1567.</a></li><li><a class="nounderline abstract_t">Chow DC, B1eikh SH, Eickhoff L, et al. Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer. Am J Gastroenterol 1996; 91:602.</a></li><li><a class="nounderline abstract_t">Wilcox CM. Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. Aliment Pharmacol Ther 1994; 8:347.</a></li><li><a class="nounderline abstract_t">Wilcox CM, Straub RF, Alexander LN, Clark WS. Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy. Am J Med 1996; 101:599.</a></li><li><a class="nounderline abstract_t">Wilcox CM, Rodgers W, Lazenby A. Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol 2004; 2:564.</a></li><li><a class="nounderline abstract_t">Levine MS. Radiology of esophagitis: a pattern approach. Radiology 1991; 179:1.</a></li><li><a class="nounderline abstract_t">Connolly GM, Forbes A, Gleeson JA, Gazzard BG. Investigation of upper gastrointestinal symptoms in patients with AIDS. AIDS 1989; 3:453.</a></li></ol></div><div id="topicVersionRevision">Topic 3726 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15745077" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7484995" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2548933" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1651690" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8633520" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7918932" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9003106" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15224280" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2006257" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Radiology of esophagitis: a pattern approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2504250" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Investigation of upper gastrointestinal symptoms in patients with AIDS.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
